Product Code: ETC13359647 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Human Albumin Market was valued at USD 17.8 Billion in 2024 and is expected to reach USD 34.9 Billion by 2031, growing at a compound annual growth rate of 11.40% during the forecast period (2025-2031).
The Global Human Albumin Market is a growing sector driven by factors such as an increasing prevalence of chronic conditions like liver cirrhosis, kidney disease, and trauma that require human albumin for treatment. Additionally, advancements in albumin purification techniques, rising demand for albumin in pharmaceuticals for drug delivery systems and research applications, and a growing aging population contribute to market growth. The market is characterized by key players such as CSL Behring, Grifols, Octapharma, and Baxter International, who are investing in research and development to introduce innovative albumin products. Asia-Pacific region is expected to witness significant growth due to improving healthcare infrastructure and rising healthcare expenditure. However, challenges such as stringent regulatory requirements and high production costs may hinder market expansion.
The Global Human Albumin Market is experiencing growth due to the increasing prevalence of liver diseases, chronic conditions, and surgeries requiring albumin as a treatment. The market is also expanding with the rising demand for albumin in the pharmaceutical and biotech industries for drug formulation and cell culture applications. Additionally, advancements in medical technology and the development of albumin-based products are creating opportunities for market expansion. Moreover, the growing awareness about the benefits of albumin in critical care and emergency medicine settings is driving market growth. Companies are focusing on strategic collaborations, product launches, and geographic expansion to capitalize on the increasing demand for human albumin globally.
The Global Human Albumin Market faces several challenges, such as stringent regulatory requirements for albumin production and distribution, increasing competition from alternative therapies and substitutes, and pricing pressures due to the presence of generic versions of the product. Additionally, the limited availability of human plasma donors and concerns regarding the ethical sourcing of albumin pose challenges to the market. Moreover, fluctuations in the supply of human albumin due to factors like natural disasters or pandemics can impact the market dynamics. Ensuring product quality and safety standards, addressing issues related to albumin shortages, and navigating the complex regulatory landscape are key challenges faced by stakeholders in the Global Human Albumin Market.
The global human albumin market is primarily driven by factors such as an increasing prevalence of liver cirrhosis, chronic liver diseases, and other liver-related disorders that require albumin therapy for treatment. Additionally, the rising geriatric population, who are more susceptible to various health conditions requiring albumin infusion, is further propelling market growth. The growing demand for albumin in critical care settings, such as trauma care and surgeries, is also a significant driver of market expansion. Furthermore, advancements in albumin purification techniques and the development of novel albumin-based therapies are contributing to market growth by expanding the potential applications of human albumin in the healthcare sector.
Government policies related to the Global Human Albumin Market primarily focus on regulating the production, distribution, and usage of human albumin to ensure safety, quality, and availability. These policies include strict guidelines on manufacturing practices, quality control measures, and product labeling requirements to safeguard patient health. Additionally, government bodies often set price controls to prevent price manipulation and ensure affordability for patients. Regulatory agencies also oversee import and export regulations to maintain a steady supply of human albumin globally and prevent shortages. Overall, government policies play a crucial role in maintaining the integrity of the Global Human Albumin Market and safeguarding public health.
The Global Human Albumin Market is poised for steady growth in the coming years, driven by increasing demand from various medical applications such as treatment of burns, liver diseases, and septic shock. Factors such as rising geriatric population, growing prevalence of chronic diseases, and advancements in biopharmaceutical research are expected to fuel market expansion. Additionally, the market is likely to benefit from the escalating adoption of albumin in drug formulation and delivery systems. However, challenges such as stringent regulatory requirements and the emergence of alternative therapies may pose a hindrance to market growth. Overall, the Global Human Albumin Market is anticipated to witness sustained growth opportunities, with key players focusing on product innovation and strategic collaborations to capitalize on the expanding market landscape.
In the global human albumin market, Asia is expected to witness significant growth due to the rising prevalence of chronic diseases and increasing healthcare expenditure in countries like China and India. North America is likely to dominate the market due to the presence of well-established healthcare infrastructure and a high demand for albumin in therapeutic applications. Europe is expected to show steady growth supported by the increasing geriatric population and advancements in albumin purification technologies. In the Middle East and Africa region, the market is projected to grow steadily due to improving healthcare facilities and rising awareness about the benefits of albumin in critical care settings. Latin America is also anticipated to experience growth with the increasing adoption of albumin in surgeries and trauma cases.
Global Human Albumin Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Human Albumin Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Human Albumin Market Revenues & Volume, 2021 & 2031F |
3.3 Global Human Albumin Market - Industry Life Cycle |
3.4 Global Human Albumin Market - Porter's Five Forces |
3.5 Global Human Albumin Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Human Albumin Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Global Human Albumin Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.8 Global Human Albumin Market Revenues & Volume Share, By Purity Level, 2021 & 2031F |
3.9 Global Human Albumin Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.10 Global Human Albumin Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
4 Global Human Albumin Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Human Albumin Market Trends |
6 Global Human Albumin Market, 2021 - 2031 |
6.1 Global Human Albumin Market, Revenues & Volume, By Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Human Albumin Market, Revenues & Volume, By Human Albumin, 2021 - 2031 |
6.1.3 Global Human Albumin Market, Revenues & Volume, By Recombinant, 2021 - 2031 |
6.1.4 Global Human Albumin Market, Revenues & Volume, By Plasma-derived, 2021 - 2031 |
6.1.5 Global Human Albumin Market, Revenues & Volume, By Human-based, 2021 - 2031 |
6.2 Global Human Albumin Market, Revenues & Volume, By Source, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Human Albumin Market, Revenues & Volume, By Plasma, 2021 - 2031 |
6.2.3 Global Human Albumin Market, Revenues & Volume, By Recombinant, 2021 - 2031 |
6.2.4 Global Human Albumin Market, Revenues & Volume, By Plasma, 2021 - 2031 |
6.2.5 Global Human Albumin Market, Revenues & Volume, By Blood Plasma, 2021 - 2031 |
6.3 Global Human Albumin Market, Revenues & Volume, By Purity Level, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Human Albumin Market, Revenues & Volume, By 98%+, 2021 - 2031 |
6.3.3 Global Human Albumin Market, Revenues & Volume, By >99%, 2021 - 2031 |
6.3.4 Global Human Albumin Market, Revenues & Volume, By 95%+, 2021 - 2031 |
6.3.5 Global Human Albumin Market, Revenues & Volume, By 1, 2021 - 2031 |
6.4 Global Human Albumin Market, Revenues & Volume, By Application, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Human Albumin Market, Revenues & Volume, By Critical Care, 2021 - 2031 |
6.4.3 Global Human Albumin Market, Revenues & Volume, By Immune Deficiencies, 2021 - 2031 |
6.4.4 Global Human Albumin Market, Revenues & Volume, By Burns, 2021 - 2031 |
6.4.5 Global Human Albumin Market, Revenues & Volume, By Liver Diseases, 2021 - 2031 |
6.5 Global Human Albumin Market, Revenues & Volume, By Dosage Form, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Human Albumin Market, Revenues & Volume, By Injectable, 2021 - 2031 |
6.5.3 Global Human Albumin Market, Revenues & Volume, By Intravenous, 2021 - 2031 |
6.5.4 Global Human Albumin Market, Revenues & Volume, By Infusion, 2021 - 2031 |
6.5.5 Global Human Albumin Market, Revenues & Volume, By Intramuscular, 2021 - 2031 |
7 North America Human Albumin Market, Overview & Analysis |
7.1 North America Human Albumin Market Revenues & Volume, 2021 - 2031 |
7.2 North America Human Albumin Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Human Albumin Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Human Albumin Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Human Albumin Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Human Albumin Market, Revenues & Volume, By Type, 2021 - 2031 |
7.4 North America Human Albumin Market, Revenues & Volume, By Source, 2021 - 2031 |
7.5 North America Human Albumin Market, Revenues & Volume, By Purity Level, 2021 - 2031 |
7.6 North America Human Albumin Market, Revenues & Volume, By Application, 2021 - 2031 |
7.7 North America Human Albumin Market, Revenues & Volume, By Dosage Form, 2021 - 2031 |
8 Latin America (LATAM) Human Albumin Market, Overview & Analysis |
8.1 Latin America (LATAM) Human Albumin Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Human Albumin Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Human Albumin Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Human Albumin Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Human Albumin Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Human Albumin Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Human Albumin Market, Revenues & Volume, By Type, 2021 - 2031 |
8.4 Latin America (LATAM) Human Albumin Market, Revenues & Volume, By Source, 2021 - 2031 |
8.5 Latin America (LATAM) Human Albumin Market, Revenues & Volume, By Purity Level, 2021 - 2031 |
8.6 Latin America (LATAM) Human Albumin Market, Revenues & Volume, By Application, 2021 - 2031 |
8.7 Latin America (LATAM) Human Albumin Market, Revenues & Volume, By Dosage Form, 2021 - 2031 |
9 Asia Human Albumin Market, Overview & Analysis |
9.1 Asia Human Albumin Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Human Albumin Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Human Albumin Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Human Albumin Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Human Albumin Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Human Albumin Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Human Albumin Market, Revenues & Volume, By Type, 2021 - 2031 |
9.4 Asia Human Albumin Market, Revenues & Volume, By Source, 2021 - 2031 |
9.5 Asia Human Albumin Market, Revenues & Volume, By Purity Level, 2021 - 2031 |
9.6 Asia Human Albumin Market, Revenues & Volume, By Application, 2021 - 2031 |
9.7 Asia Human Albumin Market, Revenues & Volume, By Dosage Form, 2021 - 2031 |
10 Africa Human Albumin Market, Overview & Analysis |
10.1 Africa Human Albumin Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Human Albumin Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Human Albumin Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Human Albumin Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Human Albumin Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Human Albumin Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Human Albumin Market, Revenues & Volume, By Type, 2021 - 2031 |
10.4 Africa Human Albumin Market, Revenues & Volume, By Source, 2021 - 2031 |
10.5 Africa Human Albumin Market, Revenues & Volume, By Purity Level, 2021 - 2031 |
10.6 Africa Human Albumin Market, Revenues & Volume, By Application, 2021 - 2031 |
10.7 Africa Human Albumin Market, Revenues & Volume, By Dosage Form, 2021 - 2031 |
11 Europe Human Albumin Market, Overview & Analysis |
11.1 Europe Human Albumin Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Human Albumin Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Human Albumin Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Human Albumin Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Human Albumin Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Human Albumin Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Human Albumin Market, Revenues & Volume, By Type, 2021 - 2031 |
11.4 Europe Human Albumin Market, Revenues & Volume, By Source, 2021 - 2031 |
11.5 Europe Human Albumin Market, Revenues & Volume, By Purity Level, 2021 - 2031 |
11.6 Europe Human Albumin Market, Revenues & Volume, By Application, 2021 - 2031 |
11.7 Europe Human Albumin Market, Revenues & Volume, By Dosage Form, 2021 - 2031 |
12 Middle East Human Albumin Market, Overview & Analysis |
12.1 Middle East Human Albumin Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Human Albumin Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Human Albumin Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Human Albumin Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Human Albumin Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Human Albumin Market, Revenues & Volume, By Type, 2021 - 2031 |
12.4 Middle East Human Albumin Market, Revenues & Volume, By Source, 2021 - 2031 |
12.5 Middle East Human Albumin Market, Revenues & Volume, By Purity Level, 2021 - 2031 |
12.6 Middle East Human Albumin Market, Revenues & Volume, By Application, 2021 - 2031 |
12.7 Middle East Human Albumin Market, Revenues & Volume, By Dosage Form, 2021 - 2031 |
13 Global Human Albumin Market Key Performance Indicators |
14 Global Human Albumin Market - Export/Import By Countries Assessment |
15 Global Human Albumin Market - Opportunity Assessment |
15.1 Global Human Albumin Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Human Albumin Market Opportunity Assessment, By Type, 2021 & 2031F |
15.3 Global Human Albumin Market Opportunity Assessment, By Source, 2021 & 2031F |
15.4 Global Human Albumin Market Opportunity Assessment, By Purity Level, 2021 & 2031F |
15.5 Global Human Albumin Market Opportunity Assessment, By Application, 2021 & 2031F |
15.6 Global Human Albumin Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
16 Global Human Albumin Market - Competitive Landscape |
16.1 Global Human Albumin Market Revenue Share, By Companies, 2024 |
16.2 Global Human Albumin Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |